No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:145450400-145469200 |
Weak transcription |
Aorta |
Aorta
|
2 |
chr2:145457200-145464600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
3 |
chr2:145457800-145463600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
4 |
chr2:145458600-145463200 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
5 |
chr2:145458600-145464400 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
6 |
chr2:145459000-145461400 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
7 |
chr2:145459000-145462000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
8 |
chr2:145459600-145463800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
9 |
chr2:145460200-145461400 |
Enhancers |
Primary B cells from cord blood |
blood
|
10 |
chr2:145461000-145461400 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
11 |
chr2:145461000-145461400 |
Enhancers |
K562 |
blood
|
12 |
chr2:145461000-145462000 |
Enhancers |
NHEK |
skin
|
13 |
chr2:145461000-145462800 |
Enhancers |
A549 |
lung
|
14 |
chr2:145461000-145463400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
15 |
chr2:145461200-145461400 |
Flanking Active TSS |
Dnd41 |
blood
|
16 |
chr2:145461200-145461800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
17 |
chr2:145461200-145461800 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
18 |
chr2:145461200-145461800 |
Enhancers |
Hela-S3 |
cervix
|
19 |
chr2:145461200-145462200 |
Enhancers |
NHDF-Ad |
bronchial
|
20 |
chr2:145461200-145462400 |
Enhancers |
HMEC |
breast
|
21 |
chr2:145461200-145463800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|